Achalasia is rare disorder. It is also known as cardiospasm or dyssynergia esophagus. Achalasia is a disorder of the esophagus, which is a muscular tube that carries food from the throat to the stomach. Esophagus is about eight inches long, and is lined by moist pink tissue called mucosa.

Signs and symptoms of achalasia, such as, mild chest pain, pain while swallowing, coughing during the night, keratoconjunctivitis sicca, and xerostomia typically appear gradually. Scientists believe that aspiration of saliva and food contents causes pneumonia, pulmonary infections, and even death. Achalasia is a rare disorder which affects mostly adults in the age group of 25 to 60 years. It affects children as well. The ratio of male and female population affected with achalasia is equal.

The cause of achalasia is unknown. X-ray examinations are frequently used to diagnosis the disorder.

Increase in the prevalence of achalasia worldwide is anticipated to boost the achalasia diagnostic and treatment market during the forecast period. Lifestyle changes are also fueling the market. Rise in government prioritization for drugs for rare disorders is also likely to boost the achalasia diagnostic and treatment market in the near future. However, lack of knowledge about achalasia is major restrain of the market. Dearth of health care experts in Latin America and Middle East & Africa also limits the growth of the achalasia diagnostic and treatment market. Nevertheless, increasing government funding for diagnosis procedure has opened growth opportunities for achalasia diagnostic and treatment market.

The global achalasia diagnostic and treatment market can be segmented based on treatment, diagnostic test, end-user, and region. In terms of treatment, the market can be classified into long-acting nitrate, calcium channel blocker, and surgery. Isosorbide is long-acting nitrate drug used for the treatment of achalasia. Calcium channel blocker, such as, nifedipine also helps prevent achalasia. Pneumatic balloon dilation is a procedure used to treat achalasia patients. Investigational therapies are undergoing clinical assessments for providing better results of achalasia treatment. The main goal of achalasia treatment is removing obstructions caused by the failure of the lower esophageal sphincter muscle to relax.

In term of diagnostic test, X-ray examination is considered the gold standard for achalasia diagnosis. Radiological examination with barium shows better results of achalasia.

Based on end-user, the global achalasia diagnostic and treatment market can be categorized into hospitals, specialized clinics, and others. In terms of revenue, the hospitals segment held a prominent share of the market in 2017.

In terms of region, the global achalasia diagnostic and treatment market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for a significant share of the global market in 2017, followed by Europe and Asia Pacific. The U.S. held a major share of the market in North America in terms of revenue. The achalasia diagnostic and treatment market in Asia Pacific is growing rapidly due to increase in the number of patients suffering from the disorder in the region. Asia Pacific is projected to be a highly attractive market for achalasia diagnostic and treatment in the near future. This is due to the presence of emerging economies such as India and China in the region. Moreover, factors such as better health care infrastructure, economic growth, rise in the number of insurance payers, expanding and developing private health care sector, and increase in awareness among people regarding achalasia diagnostic and treatment are expected to propel the market in the region in the next few years. The achalasia diagnostic and treatment market in Latin America and Middle East & Africa is projected to expand at a moderate growth rate from 2018 to 2026.

Key players operating in the global achalasia diagnostic and treatment market include Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Pharmaceuticals, Inc., Hikma Pharmaceuticals PLC., Bausch Health, Osmotica Pharmaceuticals plc., Mylan N.V., and Novartis AG.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Achalasia Diagnostic Treatment Market